Pursuing progress in acute coronary syndromes

Circulation. 1999 Oct 12;100(15):1586-9. doi: 10.1161/01.cir.100.15.1586.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Acute Disease
  • Angina, Unstable / drug therapy
  • Anticoagulants / administration & dosage
  • Anticoagulants / adverse effects
  • Anticoagulants / therapeutic use
  • Clinical Trials as Topic
  • Coronary Disease / drug therapy*
  • Enoxaparin / administration & dosage
  • Enoxaparin / adverse effects
  • Enoxaparin / therapeutic use
  • Fibrinolytic Agents / administration & dosage
  • Fibrinolytic Agents / adverse effects
  • Fibrinolytic Agents / therapeutic use*
  • Hemorrhage / chemically induced
  • Heparin, Low-Molecular-Weight / therapeutic use
  • Hospitalization
  • Humans
  • Injections, Subcutaneous
  • Meta-Analysis as Topic
  • Myocardial Infarction / prevention & control
  • Recurrence
  • Thrombolytic Therapy*
  • Treatment Outcome

Substances

  • Anticoagulants
  • Enoxaparin
  • Fibrinolytic Agents
  • Heparin, Low-Molecular-Weight